University of Cambridge > Talks.cam > GIPA seminar series > Genetic Engineering of Hematopoiesis to treat inherited diseases and cancer

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹī¸ Information

Genetic Engineering of Hematopoiesis to treat inherited diseases and cancer

Download to your calendar using vCal

If you have a question about this talk, please contact Luigi Aloia .

Prof. Naldini described for the first time the use of lentiviral vectors for gene transfer into non-dividing cells in 1996. He is a leading scientist in the field of gene therapy with the final goal of therapeutic translation. The team led by Prof. Naldin

Abstract not available

This talk is part of the GIPA seminar series series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Wolfson Lecture Theatre, Churchill College, Storey's Way, Cambridge Room GS15 at the William Gates Building and on Zoom: https://cl-cam-ac-uk.zoom.us/j/4361570789?pwd=Nkl2T3ZLaTZwRm05bzRTOUUxY3Q4QT09&from=addon Seminar room 3.37, Wellcome Trust/MRC Building, Cambridge Biomedical Campus

Other talks

How Much Does Homology Really Know? Title to be confirmed Group Work Complete and Submit Project Choice Forms Talk TBC title abstract tbc
 

Š 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity